Metronidazole Baxter Healthcare

Metronidazole, the active ingredient in Metronidazole Baxter Healthcare, is a nitroimidazole antibiotic presented as an injection for intravenous use. It treats anaerobic bacterial and protozoal infections in adults and children as prescribed.

GNH USA supplies Metronidazole Baxter Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazole is indicated for a range of anaerobic bacterial and protozoal infections. - Anaerobic bacterial infections: effective in eradicating susceptible anaerobic organisms. - Intra‑abdominal infections: helps control mixed aerobic‑anaerobic infections after surgery. - Pelvic inflammatory disease: reduces pathogen load and alleviates symptoms. - Bacterial vaginosis: restores normal vaginal flora by targeting Gardnerella species. - Trichomoniasis: eliminates Trichomonas vaginalis in genital infections. - Clostridioides difficile infection: used as part of therapy for toxin‑producing strains.

Metronidazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Headache: occasional dull or throbbing pain. - Diarrhea: loose stools during therapy. - Abdominal pain: cramping or discomfort. - Dizziness: light‑headed feeling.

Serious or Rare Side Effects: - Seizures: rare neurologic events. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: anaphylaxis or rash. - Stevens‑Johnson syndrome: serious skin eruption. - Hepatic dysfunction: elevated liver enzymes. - Neutropenia: reduced white blood cell count.

Metronidazole requires careful monitoring in several clinical situations. - Renal impairment: adjust dosing and monitor renal function. - Hepatic dysfunction: assess liver enzymes before and during therapy. - Alcohol consumption: avoid due to disulfiram‑like reaction. - Pregnancy: Category B; use only when benefit outweighs risk. - Concurrent warfarin therapy: monitor INR closely for increased anticoagulation. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Metronidazole can interact with several medicines, affecting safety or efficacy.

Major Interactions (Avoid): - Alcohol: may cause severe disulfiram‑like reaction. - Warfarin: increased anticoagulant effect, risk of bleeding. - Lithium: heightened lithium toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: may raise metronidazole plasma levels. - Phenobarbital: may reduce metronidazole effectiveness. - Phenytoin: may lower drug concentrations, reducing efficacy.